Tap here to turn on desktop notifications to get the news sent straight to you.
Join HuffPost Plus
Buero Monaco via Getty Images
Without Price Breaks, Rural Hospitals Struggle To Stock Costly, Lifesaving Drugs
By Sarah Jane Tribble, Kaiser Health News
An obscure Obamacare provision forces rural hospitals to pay full price for drugs that many bigger hospitals buy at deeply discounted rates.
Justin Sullivan via Getty Images
The Story Of The Suicide Of A Powerful Lobbyist Threatens To Rock K Street
The death of a pioneer in black arts lobbying has Washington operatives pointing fingers and lawyering up.
Raising the Bar on Corporate Wellness
Michael Finkelstein, MD
The Slow Medicine Doctor
A growing number of companies - from hi-tech corporations like Yahoo and Intel, to healthcare corporations like Kaiser Permanente and Genentech - are taking a more holistic and sophisticated view of health.
Why Boomer Aging Means Trillions of Dollars for Business
Author and speaker focused on business, aging, and societal tr...
Horrific outcomes predicted by generational accountants and economic doomsayers will not come true as foreseen, partly because the generations over age fifty shift paradigms, create new industries, abolish others, and ultimately reshape the social and economic landscape.
Core of the Core
Mary Ellen Hannibal
One of the reasons Silicon Valley has become such a popular locus for the technology revolution is that it is darn beautiful here. The weather is salubrious, perhaps too hot in the most intense part of summer, but mostly temperate.
Corporate Party Favors at the Inaugural Shindig
Former senior writer, BillMoyers.com. President, Writers Guild...
Despite reports of corporate and other highrollers offended at alleged aloofness and a lack of perks from the White House during the first term, this time, they'll be welcomed with open arms. The president said it himself -- he likes a good party.
Novel Drug Shows Promise in Her2+ Form of Breast Cancer
journalist, health care advocate, physician
A new drug called T-DM1 appears to be relatively effective and safe for women with metastatic, Her2+ breast cancer, in itself and as compared to the standard XL regimen.
A Prenatal Link To Alzheimer's?
New research at Genentech Inc. is challenging conventional thinking about Alzheimer's disease, providing a provocative theory
Newsflash: Breast Cancer Sucks, and You Can Die From It
Small girl, LARGE opinions
Maybe a reality check isn't something you want when you're being bombarded with "Breast Cancer Awareness" messages. After all, that would be kind of scary.
Genentech, Innovative Cancer Drug Maker, Receives $43.7B Offer From Roche Holding
PARIS -- The Swiss drug maker Roche Holding said Monday that it was offering about $43.7 billion to acquire the 44 percent
Do you have info to share with HuffPost reporters?
The Best Stocks For 2008
We'll say this for the U.S. economy: It can take a punch. Consider the blows it has absorbed just this year. The worst real
Real Life. Real News. Real Voices.
Help us tell more of the stories that matter from voices that too often remain unheard.
Join HuffPost Plus
Culture & Arts
TV & Film
Style & Beauty
Food & Drink
Home & Living
Impact: Project Zero
Impact: This New World
Listen to America
From Our Partners
What's Working: Purpose + Profit